In 2018, after nearly two decades working in Big Pharma, chemist Tim Cernak was ready to put his skills to a new use.  For Merck, he’d developed precision therapies for cancer, HIV, and diabetes
Kategori: Teknoloji
Haberin tamamını oku →
Gözlem Hattı Ana Sayfa
Hakkımızda | Gizlilik Politikası